More about

Proliferative Vitreoretinopathy

News
July 23, 2024
1 min read
Save

Patients may benefit from early epiretinal membrane peel after PVR repair

Patients with epiretinal membrane after proliferative vitreoretinopathy repair may benefit from early peeling, according to a study presented at the American Society of Retina Specialists annual meeting.

News
August 03, 2023
1 min read
Save

Infliximab may improve visual acuity in PVR associated with RRD

SEATTLE — Patients with proliferative vitreoretinopathy experienced improved visual acuity after receiving an intravitreal injection of infliximab after pars plana vitrectomy, according to a study.

News
December 13, 2022
10 min watch
Save

VIDEO: Surgeon shares retinectomy technique, indications for treatment

NEW YORK — In a presentation at OSN New York Retina, Stanley Chang, MD, shares pearls on effectively performing retinectomy in proliferative vitreoretinopathy and discusses when it is an appropriate treatment option.

News
December 30, 2021
1 min read
Save

Vimentin at time of retinal repair may be biomarker for proliferative vitreoretinopathy

NEW ORLEANS — Increased vimentin at the time of retinal detachment repair may help predict later development of proliferative vitreoretinopathy, according to a poster presentation at the American Academy of Ophthalmology meeting.

News
June 16, 2020
1 min read
Save

ADX-2191 named orphan medicinal product in Europe

ADX-2191 was designated as an orphan medicinal product by the European Commission for the treatment of retinal detachment, according to a press release from Aldeyra Therapeutics.

News
April 15, 2020
1 min read
Save

Cannabinoid drug receives orphan drug designation for PVR prevention

Tetra Bio-Pharma received orphan drug designation from the FDA for the cannabinoid drug PPP003 to prevent proliferative vitreoretinopathy, according to a press release.

News
March 12, 2020
1 min read
Save

Aldeyra to focus on late-stage ocular disease programs

Aldeyra Therapeutics will prioritize its ocular disease programs while placing on hold clinical development in other fields as part of a strategic prioritization program, according to a press release.

News
January 08, 2020
2 min read
Save

Endoscopy-assisted PPV improves retinal reattachment rate after silicone oil removal

More than 96% of patients who underwent endoscopy-assisted pars plana vitrectomy for silicone oil removal after proliferative vitreoretinopathy-related retinal detachment repair experienced a successful retinal reattachment, according to the results of a retrospective study.

News
December 20, 2019
1 min read
Save

Aldeyra begins phase 3 proliferative vitreoretinopathy prevention trial

Aldeyra has enrolled the first patient in a phase 3 clinical trial of ADX-2191 for the prevention of recurrent retinal detachment due to proliferative vitreoretinopathy, according to a press release.

News
October 17, 2019
3 min read
Save

Hydroxychloroquine blood levels predict retinopathy in SLE

Increased hydroxychloroquine blood levels can be used to predict later hydroxychloroquine retinopathy, according to findings published in Arthritis & Rheumatology.

View more